Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis

Int J Dermatol. 2006 Mar;45(3):323-6. doi: 10.1111/j.1365-4632.2004.02464.x.

Abstract

Background: N-acetyltransferase 2 (NAT2) polymorphism may be involved in the pathogenesis of allergic contact dermatitis.

Objective: The present study was designed to evaluate whether acetylation polymorphism plays a role in the susceptibility to p-Phenylenediamine (PPD) sensitization.

Methods: The frequencies of seven NAT2 point mutations, namely G191A, C282T, T341C, C481T, G590A, A803G, and G857A, and genotypes were determined by PCR/RFLP in a total of 70 patients with allergic contact dermatitis to PPD and 100 control subjects with no history of allergy, atopy, lung disease, diabetes mellitus and cancer.

Results: Genotypes coding rapid acetylation were detected in 52.9% and 37.0% of patients with contact dermatitis and control subjects, respectively (P = 0.04). The frequency of the NAT2*4 allele and NAT2*4/*4 genotype, coding for rapid acetylation, were also significantly higher in the contact dermatitis patients than in the control subjects (P = 0.003).

Conclusion: Our results suggest an association between rapid acetylation polymorphism and susceptibility to PPD sensitization.

MeSH terms

  • Acetylation
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Arylamine N-Acetyltransferase / genetics*
  • Coloring Agents / adverse effects*
  • Coloring Agents / metabolism
  • Dermatitis, Allergic Contact / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Phenylenediamines / adverse effects*
  • Phenylenediamines / metabolism
  • Point Mutation
  • Polymorphism, Genetic

Substances

  • Coloring Agents
  • Phenylenediamines
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • 4-phenylenediamine